Last updated on July 2019

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia


Brief description of study

The objective of the study is to investigate the efficacy, safety and pharmacokinetics of four different doses of BI 425809 once daily compared to placebo given for 12 weeks in patients with schizophrenia on stable antipsychotic treatment.

Clinical Study Identifier: NCT02832037

Find a site near you

Start Over

Synergy San Diego

Lemon Grove, CA United States
  Connect »

NRC Research Institute

Orange, CA United States
  Connect »

Alliance for Wellness

Panorama City, CA United States
  Connect »

CNRI - Los Angeles

Pico Rivera, CA United States
  Connect »

CNRI-San Diego, LLC

San Diego, CA United States
  Connect »

Synexus

Atlanta, GA United States
  Connect »

Atlanta Center

Atlanta, GA United States
  Connect »

Uptown Research Institute

Chicago, IL United States
  Connect »

Lake Charles Clinical Trials LLC

Lake Charles, LA United States
  Connect »

Neurobehavioral Research, Inc.

Cedarhurst, NY United States
  Connect »

Midwest Clinical Research

Dayton, OH United States
  Connect »

InSite Clinical Research

DeSoto, TX United States
  Connect »

Severance Hospital

Seoul, Korea, Republic of
  Connect »

Asan Medical Center

Seoul, Korea, Republic of
  Connect »

Hospital Puerta de Hierro

Majadahonda (Madrid), Spain
  Connect »

NCKUH

Tainan, Taiwan
  Connect »

Bushey Fields Hospital

Dudley, United Kingdom
  Connect »

Royal Edinburgh Hospital

Edinburgh, United Kingdom
  Connect »

Kishiro Mental Clinic

Kanagawa, Kawasaki, Japan
  Connect »

Finger Lakes Clinical Research

Rochester, NY United States
  Connect »

IUSMQ

Quebec, QC Canada
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.